Position in GSK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$458,675
-$24,237 QoQ
Shares Held
8,750
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#494
of 1,033 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alan B Lancz & Associates, Inc. holds $11,378,733 across 9 Drug Manufacturers - General names. GSK ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
9,730 | $3,523,427 | |
| 2 | LLY |
ELI LILLY & Co
|
1,415 | $1,697,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,973 | $1,538,530 | |
| 4 | JNJ |
Johnson & Johnson
|
5,537 | $1,406,231 | |
| 5 | ABBV |
AbbVie Inc.
|
4,402 | $1,107,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,990 | $1,009,456 | |
| 7 | GSK |
GSK plc
This page
|
8,750 | $458,675 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,550 | $319,791 |
All Filings in GSK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $458,675 | 8,750 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $482,912 | 8,750 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $471,764 | 9,620 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $415,199 | 9,620 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $375,552 | 9,780 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $406,770 | 10,500 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $359,168 | 10,620 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $445,592 | 10,900 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $419,650 | 10,900 | Shares | Sole | 2024-07-24 | |
| 2023-12-31 | $409,883 | 11,060 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $411,800 | 11,360 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $413,424 | 11,600 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $415,574 | 11,680 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $357,725 | 10,180 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $633,378 | 14,825 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $641,229 | 14,825 | Shares | Sole | 2022-04-13 | |
| No filing history on record for this holder in this stock. | ||||||